{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:01:55Z","timestamp":1767135715916,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd008818","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,10,5]],"date-time":"2011-10-05T00:00:00Z","timestamp":1317772800000}}],"reference-count":45,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008818.pub2","type":"journal-article","created":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T12:33:55Z","timestamp":1317213235000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission"],"prefix":"10.1002","volume":"2011","author":[{"given":"Joseph","family":"Pidala","sequence":"first","affiliation":[{"name":"Division of Oncologic Sciences, University of South Florida; Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center; Tampa Florida USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Djulbegovic","sequence":"additional","affiliation":[{"name":"Center for Evidence Based Medicine and Health Outcomes Research, University of South Florida; Professor of Medicine and Oncology, H. Lee Moffitt Cancer Center; USF Health Clinical Research, 12901 Bruce B. Downs Boulevard, MDC02 Tampa Florida USA 33612"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Anasetti","sequence":"additional","affiliation":[{"name":"Division of Oncologic Sciences, University of South Florida; Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center; Tampa Florida USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Kharfan-Dabaja","sequence":"additional","affiliation":[{"name":"Division of Oncologic Sciences, University of South Florida; Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center; Tampa Florida USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambuj","family":"Kumar","sequence":"additional","affiliation":[{"name":"University of South Florida; Center for Evidence Based Medicine and Health Outcomes Research; Tampa Florida USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,10,5]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD008818.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood.V86.4.1619.bloodjournal8641619","article-title":"Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group","volume":"86","author":"Attal","year":"1995","journal-title":"Blood"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0002|cit2","first-page":"204","article-title":"Early intensification followed by allo-BMT or auto-BMT or a second intensification in adult ALL: a randomized multicenter study","volume":"6","author":"Bernasconi","year":"1992","journal-title":"Leukemia"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1182\/blood-2008-07-168625","article-title":"Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison","volume":"113(6)","author":"Cornelissen","year":"2009","journal-title":"Blood"},{"issue":"5","key":"10.1002\/14651858.CD008818.pub2-BIB0004|cit4","first-page":"767","article-title":"Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission","volume":"14","author":"Witte","year":"1994","journal-title":"Bone Marrow Transplant"},{"issue":"19","key":"10.1002\/14651858.CD008818.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1182\/blood-2009-01-199380","article-title":"Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXI \/ECOG2993","volume":"113","author":"Fielding","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD008818.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2007-10-116582","article-title":"In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation\/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII\/ECOG E2993)","volume":"111","author":"Goldstone","year":"2008","journal-title":"Blood"},{"issue":"10","key":"10.1002\/14651858.CD008818.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1182\/blood-2003-10-3560","article-title":"Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial","volume":"104","author":"Hunault","year":"2004","journal-title":"Blood"},{"issue":"(8)","key":"10.1002\/14651858.CD008818.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1496::AID-CNCR16>3.0.CO;2-#","article-title":"Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia. GOELAMS Group","volume":"86","author":"Ifrah","year":"1999","journal-title":"Cancer"},{"issue":"7","key":"10.1002\/14651858.CD008818.pub2-BIB0009|cit9","first-page":"809","article-title":"Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients < or = 50 years old in first complete remission: results of the EORTC ALL-3 trial","volume":"89","author":"Labar","year":"2004","journal-title":"Haematologica"},{"issue":"10","key":"10.1002\/14651858.CD008818.pub2-BIB0010|cit10","first-page":"1346","article-title":"Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial","volume":"90","author":"Ribera","year":"2005","journal-title":"Haematologica"},{"issue":"12","key":"10.1002\/14651858.CD008818.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1200\/JCO.1994.12.12.2580","article-title":"Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia","volume":"12","author":"Sebban","year":"1994","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"10.1002\/14651858.CD008818.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/sj.leu.2402526","article-title":"Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study","volume":"16","author":"Takeuchi","year":"2002","journal-title":"Leukemia"},{"issue":"20","key":"10.1002\/14651858.CD008818.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1200\/JCO.2004.10.050","article-title":"Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial","volume":"22","author":"Thomas","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD008818.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0925-5710(98)00075-9","article-title":"Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: the ALL90 study of the Japan Adult Leukemia Study Group","volume":"68","author":"Ueda","year":"1998","journal-title":"International Journal of Hematology"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0015|cit15","unstructured":"Als-Nielsen B Gluud LL Gluud C Methodological quality and treatment effects in randomized trials: a review of six empirical studies 12th Cochrane Colloquium 2004"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood.V99.3.863","article-title":"Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study","volume":"99","author":"Annino","year":"2002","journal-title":"Blood"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.thj.6200091","article-title":"Risk-oriented post-remission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groups","volume":"2","author":"Bassan","year":"2001","journal-title":"Hematology Journal"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"315","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jclinepi.2005.04.006","article-title":"A review of blinding in randomized controlled trials found results inconsistent and questionable","volume":"58","author":"Boutron","year":"2005","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/bmj.38356.424606.8F","article-title":"Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors","volume":"330","author":"Chan","year":"2005","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0021|cit21","article-title":"Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated September 2008)","volume-title":"The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org","author":"Deeks","year":"2008"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"7","key":"10.1002\/14651858.CD008818.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1182\/blood-2002-03-0704","article-title":"Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 trial","volume":"100","author":"Dombret","year":"2002","journal-title":"Blood"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1046\/j.1365-2141.2002.03685.x","article-title":"High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia","volume":"118","author":"Hallbrook","year":"2002","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1136\/bmj.38446.498542.8F","article-title":"Optimal search strategies for retrieving scientifically strong studies of treatment from MEDLINE: analytical survey","volume":"330","author":"Haynes","year":"2005","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0029|cit29","article-title":"Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated September 2008)","volume-title":"The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org","author":"Higgins","year":"2008"},{"issue":"2","key":"10.1002\/14651858.CD008818.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2141.2008.07185.x","article-title":"Status of minimal residual disease after induction predicts outcome in both standard and high-risk Ph-negative adult acute lymphoblastic leukaemia. The Polish Adult Leukemia Group ALL 4-2002 MRD Study","volume":"142","author":"Holowiecki","year":"2008","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: assessing the quality of controlled clinical trials","volume":"323","author":"J\u00fcni","year":"2001","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1002\/cncr.20668","article-title":"Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia","volume":"101","author":"Kantarjian","year":"2004","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0033|cit33","first-page":"1556","article-title":"A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111","volume":"92","author":"Larson","year":"1998","journal-title":"Blood"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1200\/JCO.2002.07.116","article-title":"Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia","volume":"20","author":"Linker","year":"2002","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/jama.295.6.676","article-title":"Comparison of two methods to detect publication bias in meta-analysis","volume":"95","author":"Peters","year":"2006","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1002\/cncr.25136","article-title":"Management of adult patients with acute lymphoblastic leukemia in first complete remission: systematic review and meta-analysis","volume":"116","author":"Ram","year":"2010","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0140-6736(02)08029-7","article-title":"Unequal group sizes in randomised trials: guarding against guessing","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.seminhematol.2008.09.007","article-title":"Treatment of childhood acute lymphoblastic leukemia","volume":"46","author":"Stanulla","year":"2009","journal-title":"Seminars in Hematology"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","article-title":"Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis","volume":"54","author":"Sterne","year":"2001","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0042|cit42","article-title":"Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.0.1 (updated September 2008)","volume-title":"The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org","author":"Sterne","year":"2008"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0889-8588(05)70190-8","article-title":"Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA-87","volume":"14","author":"Thiebaut","year":"2000","journal-title":"Hematology Oncology Clinics of North America"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ije\/dyg313","article-title":"Commentary: Mendelian randomization? An update on its use to evaluate allogeneic stem cell transplantation in leukaemia","volume":"33","author":"Wheatley","year":"2004","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD008818.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1002\/cncr.21932","article-title":"Allogeneic hematopoietic stem cell transplantation as part of post-remission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a meta-analysis","volume":"106","author":"Yanada","year":"2006","journal-title":"Cancer"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD008818.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T04:32:32Z","timestamp":1751603552000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008818.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Haematological Malignancies Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,10,5]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2011,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008818.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,5]]}}}